Core Viewpoint - This year's flu season is unusual, arriving early and exhibiting a more severe impact compared to previous years, with a significant increase in infections among the population [1][3]. Group 1: Virus Characteristics - The "K strain" is not a new virus but a variant of the H3N2 influenza virus, which has undergone minor mutations, making it more adept at evading the immune system [3][4]. - The H3N2 strain has become the dominant virus this season, accounting for over 95% of cases, while H1N1 and B strains have nearly disappeared [4]. - The mutations in the H3N2 strain have increased its ability to adhere to human respiratory cells by approximately 1.8 times compared to previous strains, facilitating rapid transmission in group settings [4][5]. Group 2: Co-circulating Viruses - Multiple respiratory viruses, including RSV and adenoviruses, are also circulating, leading to compounded infections where individuals may recover from one virus only to be infected by another [5]. - The presence of the K strain does not necessarily lead to more severe symptoms compared to other flu strains, but the speed of onset and overall symptoms may be more pronounced [5]. Group 3: Vaccine Efficacy - The current flu vaccines, both trivalent and quadrivalent, are effective against the H3N2 strain and the K variant, providing significant protection against severe illness [6][7]. - Vaccination rates in China are low, at around 3%, compared to 40-50% in developed countries, which hampers the establishment of herd immunity [7]. - Vaccination is still valuable even if individuals have been exposed to the virus, as long as they are not in the acute phase of illness [7]. Group 4: Current Situation and Recommendations - As of December 2025, flu activity is showing signs of decline, but the risk of rebound remains, necessitating continued vigilance in flu prevention [8].

Core Viewpoint - The article emphasizes the urgent need for increased COVID-19 vaccination rates in China, which currently stands at only around 9%. It highlights the importance of vaccination in the context of economic reopening and the challenges posed by virus mutations [1][2][4]. Vaccination Status and Challenges - The vaccination rate in China is notably low at approximately 9%, attributed to public perception of safety and concerns over side effects. This poses a risk as the country prepares for economic reopening [2][4]. - The global vaccination effort is ongoing, with the U.S. leading in total doses administered, followed by China. However, when considering doses per 100 people, countries like Israel and the UAE rank higher [4]. - The effectiveness of Chinese vaccines, such as Sinovac, is highlighted, with a 100% prevention rate for severe cases and hospitalizations, despite varying efficacy rates in preventing infections across different countries [5][4]. Virus Mutation and Its Impact - Virus mutations present significant challenges to vaccine effectiveness and antibody treatments. The duration of vaccine efficacy remains uncertain due to ongoing mutations [5][10]. - Current research indicates that some monoclonal antibodies may lose effectiveness against certain virus strains, necessitating global cooperation to address these challenges [10].